📰 Expanded Access Protocol News
Page 2 - Expanded Access Protocol News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Expanded Access Protocol. Real-time updates on events, politics, business and more.
May 3, 2022
HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM:HCM; HKEX:13) announced that the U.S. Food and Drug Administration (“FDA” or the “Agency”) has issued a Complete Response Letter (“CRL”) regarding the New Drug Application (“NDA”) for surufatinib for the treatment of pancreatic (“pNETs”) and ...
May 2, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
March 31, 2022
/PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), today announced that 13 abstracts, including two oral presentations, will be...
January 19, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients
January 5, 2022
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Alzheimers disease (AD) is the most common reason of progressive dementia in the elderly population....
January 5, 2022
PALM BEACH, Fla., Jan. 5, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Alzheimer's disease (AD) is the most common reason of progressive dementia in the elderly population.
January 5, 2022
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Alzheimers disease (AD) is the most common reason of progressive dementia in the elderly population....
December 29, 2021
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced...
December 27, 2021
FDA Authorizes Further NurOwn® Dosing Under Expanded Access Program - read this article along with other careers information, tips and advice on BioSpace
December 27, 2021
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced...